Posts

Citichem India IPO: A Comprehensive Analysis

Image
Citichem India Limited, a well-known player in the chemical and pharmaceutical supply chain industry, is gearing up to raise ₹12.6 crore through its Initial Public Offering (IPO). This move signals the company’s growth ambitions and provides investors with an opportunity to benefit from its expansion. Here’s a detailed look at Citichem’s IPO and its potential impact. IPO Details The following are the specifics of Citichem India’s upcoming IPO: Total Issue Size: ₹12.6 crore, comprising a fresh issue of 18,00,000 equity shares. Issue Price: ₹70 per share. Minimum Investment: ₹1,40,000 (Lot size of 2,000 shares). Open and Close Dates: December 27, 2024, to December 31, 2024. Listing Platform: The shares will list on the BSE SME Exchange. Expected Listing Date: January 3, 2025. About Citichem India Founded in 1994, Citichem India is a prominent chemical distributor focusing on sectors like pharmaceuticals, food processing, and adhesives. The company is known ...

Unimech Aerospace IPO: An Opportunity in High-Precision Engineering

Image
Unimech Aerospace and Manufacturing Limited, a leading provider of high-precision engineering solutions, has announced its Initial Public Offering (IPO) to raise ₹500 crore. Known for its expertise in sectors like aerospace, defense, energy, and semiconductors, the company is set to garner significant interest from investors. IPO Details Total Issue Size: ₹500 crore Fresh Issue: ₹250 crore Offer for Sale (OFS): ₹250 crore Price Band: ₹745 to ₹785 per share Lot Size: 19 shares Minimum Investment: ₹14,155 IPO Dates: Opens on December 23, 2024, and closes on December 26, 2024 Expected Listing Date: December 31, 2024, on BSE and NSE Company Overview Founded in 2016, Unimech Aerospace specializes in manufacturing highly complex components and systems. Its diverse product range includes aero tooling, ground support equipment, precision-engineered sub-assemblies, and custom-machined parts. The company caters to clients across seven countries, including major ...

Senores Pharmaceuticals IPO: GMP soars 46%

Senores Pharmaceuticals Ltd, a well-known name in the pharmaceutical sector, has launched its Initial Public Offering (IPO) to raise ₹582.11 crore. The IPO subscription period runs from December 20 to December 24, 2024, offering investors a new opportunity in the healthcare space. IPO Details Fresh Issue: ₹500 crore Offer for Sale: ₹82.11 crore Price Band: ₹372 to ₹391 per share Lot Size: 38 shares Minimum Investment: ₹14,858 Key Dates Opening Date: December 20, 2024 Closing Date: December 24, 2024 Allotment Date: December 26, 2024 Listing Date: December 30, 2024 Objectives of the IPO The funds raised will primarily be used for working capital, enhancing research and development efforts, and repaying existing debt. Subscription Status On the first day of bidding, the IPO was subscribed 1.86 times, with a robust response from retail investors, who oversubscribed their portion by 7.51 times. This strong participation indicates significant interest from the in...